← Open Payments lookup

YAEL SCHREIBER: Open Payments

NPI 1629375381 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 10 payments from 9 companies in 2025. Trend: 2023 $273 · 2024 $335 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
Biogen, Inc.1$107
HARMONY BIOSCIENCES LLC2$61
Neurocrine BioSciences, Inc.1$32
ABBVIE INC.1$26
Otsuka Pharmaceutical Development & Commercialization, Inc.1$23
Teva Pharmaceuticals USA, Inc.1$20
TMS NeuroHealth Centers Inc.1$17
Lundbeck LLC1$16
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: ZURZUVAE, WAKIX, INGREZZA, VRAYLAR, AUSTEDO XR, TMS NeuroHealth Centers Inc., REXULTI, TRINTELLIX.

Industry payments across MD — which companies pay providers there.